Try our mobile app

Published: 2023-05-10 18:55:07 ET
<<<  go to DOX company page
EX-99.1 2 d330821dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

 

Amdocs Limited Reports Second Quarter Fiscal 2023 Results

Record Quarterly Revenue of $1.22 Billion, Above Midpoint of Guidance and up 6.8% YoY

as Reported and 8.2% YoY in Constant Currency(2)

Reiterates Fiscal 2023 Revenue Growth Outlook while Tightening Expected Range to 6%-8% as Reported and 7%-9% Constant Currency(2)

Reiterates Fiscal 2023 Earnings per Share Growth Targets

Reiterates Fiscal 2023 Free Cash Flow(1) Outlook of $700 Million

Second Quarter Fiscal 2023 Highlights

(All comparisons are against the prior year)

 

   

Record revenue of $1,223 million, up 6.8% as reported and up 8.2% in constant currency(2); revenue was above the midpoint of $1,200-$1,240 million guidance range

 

   

Record revenue of $829 million in North America, up 7.4%, and record revenue of $172 million in Europe, up 16.6%

 

   

Record managed services revenue of $719 million, equivalent to approximately 59% of total revenue

 

   

GAAP diluted EPS of $1.23, above the midpoint of $1.18-$1.26 guidance range

 

   

Non-GAAP diluted EPS of $1.47, at the midpoint guidance range of $1.44-$1.50

 

   

GAAP operating income of $182 million; GAAP operating margin of 14.9%, up 220 basis points sequentially, primarily due to restructuring charges, and up 60 basis points as compared to last year’s second fiscal quarter

 

   

Non-GAAP operating income of $218 million; non-GAAP operating margin of 17.8%, up 10 basis points sequentially and up 20 basis points as compared to last year’s second fiscal quarter

 

(1)

Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding).

(2)

Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period


   

Free cash flow of $259 million, comprised of cash flow from operations of $294 million, less $35 million in net capital expenditures and other(1); reiterates full year fiscal 2023 free cash outlook of $700 million

 

   

Repurchased $106 million of ordinary shares during the second fiscal quarter

 

   

Record twelve-month backlog of $4.11 billion, up 5.7% as compared to last year’s second fiscal quarter

 

   

The Board of Directors of Amdocs approved a definitive agreement on May 10, 2023, to acquire the service assurance business of TEOCO for a consideration of approximately $90 million in cash, subject to closing conditions

JERSEY CITY, NJ – May 10, 2023 – Amdocs Limited (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended March 31, 2023.

“I am pleased with our second fiscal quarter performance as we progressed our strategy to deliver the next-generation cloud-based products and software services that global communications service providers need to unlock the potential of 5G and broadband networks, data-driven intelligence, and improved consumer and B2B experience. Record revenue of $1.22 billion was up 8.2% from a year ago in constant currency(2), driven by our best-ever quarters in North America and Europe, and we saw continued sales momentum with many cloud-related wins in the quarter. New deals included key awards with T-Mobile in the US, two new logos in Eastern Europe, and a significant cloud-migration engagement with PLDT in the Philippines. On the strategic front, we expanded our Microsoft partnership to bring a new AI-powered Customer Engagement Platform, and we sharpened our focus on the growth potential of B2B with the launch of CES23, our most advanced Customer Experience Suite yet. Additionally, we signed a definitive agreement to acquire the service assurance business of TEOCO to enhance the execution of our network automation strategy,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.


“Demonstrating strong execution, we maintained a high rate of project deployments in Q2, which included major milestone achievements with many of the world’s largest service providers. Driven by ongoing efficiency gains, profitability improved on a sequential and year ago basis and free cash flow generation was very strong on the back of healthy cash collections from customers. In managed services, we renewed several customer agreements which included an extended multiyear partnership with Globe in the Philippines and an expanded cloud-related engagement with a major Western European operator,” said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.

Sheffer concluded, “As said previously, Amdocs and our global customers are not immune to economic and industry cycles, and we continue to closely monitor the operating environment. As a key technology enabler, we believe Amdocs is positioned at the heart of a multi-year, technology-driven investment cycle centered around the major long-term trends of 5G, network automation, digital modernization, and cloud. Moreover, we believe Amdocs’ role as a trusted partner is even more relevant during this period of rapidly shifting market dynamics as we work to help service providers improve consumer and B2B experience, accelerate cost reduction, and increase efficiency. Overall, considering our strong first half performance and the visibility provided by our unique business model, we expect to deliver constant currency(2) revenue growth within a tighter range of 7% to 9% in fiscal 2023, while maintaining improved profitability and robust earnings to cash conversion for the full year.”

Revenue

(All comparisons are against the prior year period)

 

     In millions  
     Three months ended  
     March 31, 2023  
     Actual     Guidance  

Revenue

   $  1,223     $ 1,200 - $1,240  

Revenue Growth, as reported

     6.8  

Revenue Growth, constant currency (2)

     8.2  


   

Revenue for the second fiscal quarter of 2023 was at the midpoint of Amdocs’ guidance, even after adjusting for a positive impact from foreign currency movements of approximately $3 million compared to our guidance assumptions

 

   

Revenue for the second fiscal quarter includes a positive impact from foreign currency movements of approximately $7 million relative to the first quarter of fiscal 2023

Net Income and Earnings Per Share

 

`    In thousands, expect per
share data
 
     Three months ended  
     March 31,  
     2023      2022  

GAAP Measures

     

Net Income

   $  150,309      $  158,497  

Net Income attributable to Amdocs Limited

   $ 149,603      $ 158,497  

Diluted earnings per share

   $ 1.23      $ 1.28  

Non-GAAP Measures

     

Non-GAAP Net Income

   $ 179,298      $ 190,944  

Non-GAAP Net Income attributable to Amdocs Limited

   $ 178,592      $ 190,944  

Non-GAAP Diluted earnings per share

   $ 1.47      $ 1.54  

 

   

Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses and other, net of related tax effects, in all the periods presented.

For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

Capital Allocation: Returning Cash to Shareholders

 

   

Quarterly Cash Dividend Program: On May 10, 2023, the Board approved the Company’s next quarterly cash dividend payment of $0.435 per share and set June 30, 2023 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 28, 2023

 

   

Share Repurchase Activity: Repurchased $106 million of ordinary shares during the second quarter of fiscal 2023


Twelve-month Backlog

Twelve-month backlog was a record $4.11 billion at the end of the second quarter of fiscal 2023, up approximately 5.7% as compared to last year’s second fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.

Third Quarter Fiscal 2023 Outlook

 

     In millions, except per share data
Q3 2023

Revenue

   $1,215-$1,255

GAAP diluted EPS

   $1.16-$1.26

Non-GAAP diluted EPS

   $1.45-$1.51

 

   

Third quarter revenue guidance assumes immaterial sequential impact from foreign currency fluctuations as compared to the second quarter of fiscal 2023

 

   

Third quarter non-GAAP diluted EPS guidance excludes equity-based compensation expense of approximately $0.15-$0.17 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.08 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

Full Year Fiscal 2023 Outlook

 

     FY 2023, year-over-year growth
     Current Guidance   Previous Guidance

Revenue growth, as reported

   6.0%-8.0%   5.0%-9.0%

Revenue growth, constant currency(2)

   7.0%-9.0%   6.0%-10.0%

GAAP diluted EPS growth

   3.0%-10.0%   3.0%-10.0%

Non-GAAP diluted EPS growth

   9.0%-13.0%   9.0%-13.0%


     FY 2023, in millions
     Current Guidance    Previous Guidance

Free cash flow(1)

   ~$700    ~$700

 

   

Full year fiscal 2023 revenue guidance incorporates an expected unfavorable impact from foreign currency fluctuations of approximately 1% year-over-year, consistent with previous expectation

 

   

Non-GAAP diluted earnings per share growth excludes equity-based compensation expense of approximately $0.58-$0.63 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.35 per share, restructuring charges of approximately $0.15 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

 

   

Non-GAAP effective tax rate is anticipated to be within a range of 13.0% to 17.0% for the full year fiscal 2023

 

   

Free cash flow(1) is comprised of cash flow from operations, less net capital expenditures and other

The forward looking statements regarding our third fiscal quarter 2023 and full year fiscal 2023 guidance take into consideration the Company’s current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, global or regional events, such as the COVID-19 pandemic and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continues to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.


Conference Call and Earnings Webcast Presentation Details

Amdocs will host a conference call and earnings webcast presentation on May 10, 2023 at 5:00 p.m. Eastern Time to discuss the Company’s second quarter of fiscal 2023 results.

To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:     

 

   

amortization of purchased intangible assets and other acquisition-related costs;

 

   

changes in certain acquisition-related liabilities measured at fair value;

 

   

restructuring and unusual charges or benefits (such as a gain from divestiture of OpenMarket);

 

   

equity-based compensation expense;

 

   

other; and

 

   

tax effects related to the above.

Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.


Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.


Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

 

   

Keep up with Amdocs news by visiting the Company’s website

 

   

Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

About Amdocs

Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers’ innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our 31,000 employees around the globe are here to accelerate service providers’ migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.58 billion in fiscal 2022.

For more information, visit Amdocs at www.amdocs.com.


This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macro-economic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other global or regional events such as the COVID-19 pandemic, as well as the current inflationary environment, and the effects of these conditions on the company’s clients’ businesses and levels of business activity, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2022 filed on December 13, 2022 and our Form 6-K furnished for the first quarter of fiscal 2023 on February 13, 2023.

Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com


AMDOCS LIMITED

Consolidated Statements of Income

(In thousands, except per share data)

 

     Three months ended
March 31,
    Six months ended
March 31,
 
     2023     2022     2023     2022  

Revenue

   $ 1,223,304     $ 1,145,271     $ 2,409,024     $ 2,249,903  

Operating expenses:

        

Cost of revenue

     795,485       741,257       1,552,334       1,457,975  

Research and development

     89,274       87,064       185,000       169,009  

Selling, general and administrative

     143,328       134,982       286,550       263,058  

Amortization of purchased intangible assets and other

     12,940       18,317       28,253       36,064  

Restructuring charges

     —         —         24,536       —    
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,041,027       981,620       2,076,673       1,926,106  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     182,277       163,651       332,351       323,797  

Interest and other expense, net

     (2,938     (8,619     (7,901     (11,181

Gain from sale of a business

     —         —         —         10,000  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     179,339       155,032       324,450       322,616  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income tax expense (benefit)

     29,030       (3,465     44,269       30,517  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 150,309     $ 158,497     $ 280,181     $ 292,099  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to noncontrolling interests

     706       —         911       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Amdocs Limited

   $ 149,603     $ 158,497     $ 279,270     $ 292,099  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share attributable to Amdocs Limited

   $ 1.24     $ 1.29     $ 2.32     $ 2.36  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share attributable to Amdocs Limited

   $ 1.23     $ 1.28     $ 2.30     $ 2.34  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash dividends declared per ordinary share

   $ 0.435     $ 0.395     $ 0.830     $ 0.755  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic weighted average number of shares outstanding

     120,516       122,977       120,585       123,748  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted weighted average number of shares outstanding

     121,359       123,821       121,430       124,571  
  

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Selected Financial Metrics

(In thousands, except per share data)

 

     Three months ended
March 31,
     Six months ended
March 31,
 
     2023      2022      2023      2022  

Revenue

   $ 1,223,304      $ 1,145,271      $ 2,409,024      $ 2,249,903  

Non-GAAP operating income

     217,737        201,625        427,275        395,232  

Non-GAAP net income

     179,298        190,944        355,840        341,079  

Non-GAAP net income attributable to Amdocs Limited

     178,592        190,944        354,929        341,079  

Non-GAAP diluted earnings per share

   $ 1.47      $ 1.54      $ 2.92      $ 2.74  

Diluted weighted average number of shares outstanding

     121,359        123,821        121,430        124,571  

Free Cash Flows

(In thousands)

 

     Three months ended
March 31,
    Six months ended
March 31,
 
     2023     2022     2023     2022  

Net Cash Provided by Operating Activities

   $ 294,476     $ 168,856     $ 377,702     $ 372,974  

Purchases of property and equipment, net (a)

     (35,119     (47,271     (68,822     (104,496
  

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 259,357     $ 121,585     $ 308,880     $ 268,478  

Normalized Free Cash Flow (b) for the three and six months ended March 31, 2022: $159,758 and $345,437, respectively, excluding net capital expenditures related to the new campus development of $30,109 and $59,416, respectively, payment for acquisition related liability of $4,871 and $14,350, respectively, and tax payment on sale of business of $3,193.

 

(a)

The amounts under “Purchase of property and equipment, net” include proceeds from sale of property and equipment of $255 and $555 for the six months ended March 31, 2023 and 2022, respectively.

(b)

Since Q12023, the Normalized Free Cash Flow is no longer applicable.


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Three Months Ended March 31, 2023  
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
certain
acquisitions
related
liabilities
measured at
fair value
    Tax
effect
    Non-GAAP  

Operating expenses:

            

Cost of revenue

   $ 795,485     $ —       $ (10,061   $ (1,159   $ —       $ 784,265  

Research and development

     89,274         (1,703         87,571  

Selling, general and administrative

     143,328         (9,597         133,731  

Amortization of purchased intangible assets and other

     12,940       (12,940           —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,041,027       (12,940     (21,361     (1,159     —         1,005,567  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     182,277       12,940       21,361       1,159       —         217,737  

Interest and other expense, net

     (2,938             (2,938

Income taxes

     29,030             6,471       35,501  

Net income

     150,309       12,940       21,361       1,159       (6,471     179,298  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to noncontrolling interests

     706               706  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Amdocs Limited

   $ 149,603     $ 12,940     $ 21,361     $ 1,159     $ (6,471   $ 178,592  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Three Months Ended March 31, 2022  
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
certain
acquisitions
related
liabilities
measured at
fair value
    Other      Tax
effect
    Non-GAAP  

Operating expenses:

               

Cost of revenue

   $ 741,257     $ —       $ (8,070   $ (1,820   $ —        $ —       $ 731,367  

Research and development

     87,064         (1,375            85,689  

Selling, general and administrative

     134,982         (8,392            126,590  

Amortization of purchased intangible assets and other

     18,317       (18,317              —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Total operating expenses

     981,620       (18,317     (17,837     (1,820     —          —         943,646  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Operating income

     163,651       18,317       17,837       1,820       —          —         201,625  

Interest and other expense, net

     (8,619           1,100          (7,519

Income tax (benefit) expense

     (3,465              6,627       3,162  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Net income

   $ 158,497     $ 18,317     $ 17,837     $ 1,820     $ 1,100      $ (6,627   $ 190,944  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Six Months Ended March 31, 2023  
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
certain
acquisitions
related
liabilities
measured at
fair value
    Restructuring
charges
    Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 1,552,334     $ —       $ (18,716   $ (1,284   $ —       $ —       $ 1,532,334  

Research and development

     185,000         (3,187           181,813  

Selling, general and administrative

     286,550         (18,948           267,602  

Amortization of purchased intangible assets and other

     28,253       (28,253             —    

Restructuring charges

     24,536             (24,536       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     2,076,673       (28,253     (40,851     (1,284     (24,536     —         1,981,749  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     332,351       28,253       40,851       1,284       24,536       —         427,275  

Interest and other expense, net

     (7,901               (7,901

Income taxes

     44,269               19,265       63,534  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     280,181       28,253       40,851       1,284       24,536       (19,265     355,840  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to noncontrolling interests

     911                 911  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Amdocs Limited

   $ 279,270     $ 28,253     $ 40,851     $ 1,284     $ 24,536     $ (19,265   $ 354,929  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Six Months Ended March 31, 2022  
     GAAP     Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
certain
acquisitions
related
liabilities
measured at
fair value
    Gain from
sale of a
business
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

                

Cost of revenue

   $ 1,457,975     $ —       $ (15,217   $ (793   $ —       $ —       $ —       $ 1,441,965  

Research and development

     169,009         (2,598             166,411  

Selling, general and administrative

     263,058         (16,763             246,295  

Amortization of purchased intangible assets and other

     36,064       (36,064               —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,926,106       (36,064     (34,578     (793     —         —         —         1,854,671  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     323,797       36,064       34,578       793       —         —         —         395,232  

Interest and other expense, net

     (11,181             (2,505       (13,686

Gain from sale of a business

     10,000           $ (10,000         —    

Income tax (benefit) expense

     30,517                 9,950       40,467  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 292,099     $ 36,064     $ 34,578     $ 793     $ (10,000   $ (2,505   $ (9,950     341,079  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(In thousands)

 

     As of  
     March 31,
2023
     September 30,
2022
 

ASSETS

     

Current assets:

     

Cash and cash equivalents

   $ 623,404      $ 573,377  

Short-term interest-bearing investments

     238,163        244,603  

Accounts receivable, net, including unbilled of $166,866 and $157,165, respectively

     991,486        946,777  

Prepaid expenses and other current assets

     251,883        238,390  
  

 

 

    

 

 

 

Total current assets

     2,104,936        2,003,147  

Property and equipment, net

     797,023        794,287  

Lease assets

     157,587        176,884  

Goodwill and other intangible assets, net

     2,798,295        2,841,137  

Other noncurrent assets

     606,329        574,938  
  

 

 

    

 

 

 

Total assets

   $ 6,464,170      $ 6,390,393  
  

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current liabilities

     

Accounts payable, accruals and other

   $ 934,907      $ 955,658  

Lease liabilities

     38,319        43,336  

Deferred revenue

     351,671        253,686  
  

 

 

    

 

 

 

Total current liabilities

     1,324,897        1,252,680  

Lease liabilities

     120,170        138,378  

Long-term debt, net of unamortized debt issuance costs

     645,404        645,117  

Other noncurrent liabilities

     744,138        793,940  

Total Amdocs Limited Shareholders’ equity

     3,586,141        3,517,769  

Noncontrolling interests

     43,420        42,509  
  

 

 

    

 

 

 

Total equity

     3,629,561        3,560,278  
  

 

 

    

 

 

 

Total liabilities and equity

   $ 6,464,170      $ 6,390,393  
  

 

 

    

 

 

 


AMDOCS LIMITED

Consolidated Statements of Cash Flows

(In thousands)

 

     Six months ended
March 31,
 
     2023     2022  

Cash Flow from Operating Activities:

    

Net income

   $ 280,181     $ 292,099  

Reconciliation of net income to net cash provided by operating activities:

    

Depreciation, amortization and impairment

     103,086       101,071  

Amortization of debt issuance cost

     287       279  

Equity-based compensation expense

     40,851       34,578  

Gain from sale of a business

     —         (10,000

Deferred income taxes

     (27,357     (35,879

Loss from short-term interest-bearing investments

     1,625       1,333  

Net changes in operating assets and liabilities, net of amounts acquired:

    

Accounts receivable, net

     (53,485     (140,863

Prepaid expenses and other current assets

     (20,416     3,848  

Other noncurrent assets

     (245     3,042  

Lease assets and liabilities, net

     (3,928     (67

Accounts payable, accrued expenses and accrued personnel

     (38,602     (22,006

Deferred revenue

     81,959       102,997  

Income taxes payable, net

     (11,245     27,378  

Other noncurrent liabilities

     24,991       15,164  
  

 

 

   

 

 

 

Net cash provided by operating activities

     377,702       372,974  
  

 

 

   

 

 

 

Cash Flow from Investing Activities:

    

Purchase of property and equipment, net (a)

     (68,822     (104,496

Proceeds from sale of short-term interest-bearing investments

     10,360       13,142  

Purchase of short-term interest-bearing investments

     —         (34,275

Net cash paid for business acquisitions

     —         (24,497

Net cash received from sale of a business

     —         10,000  

Other

     (2,593     (2,958
  

 

 

   

 

 

 

Net cash used in investing activities

     (61,055     (143,084
  

 

 

   

 

 

 

Cash Flow from Financing Activities:

    

Repurchase of shares

     (205,637     (300,929

Proceeds from employee stock option exercises

     34,840       50,550  

Payments of dividends

     (95,370     (89,366

Payment of contingent consideration from a business acquisition

     (453     (6,153
  

 

 

   

 

 

 

Net cash used in financing activities

     (266,620     (345,898
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     50,027       (116,008

Cash and cash equivalents at beginning of period

     573,377       709,064  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 623,404     $ 593,056  
  

 

 

   

 

 

 


AMDOCS LIMITED

Supplementary Information

(In millions)

 

     Three months ended  
     March 31,      December 31,      September 30,      June 30,      March 31,  
     2023      2022      2022      2022      2022  

North America

   $ 829.0      $ 812.7      $ 794.4      $ 788.0      $ 772.2  

Europe

     171.7        168.7        146.4        146.1        147.2  

Rest of the World

     222.6        204.3        225.7        226.2        225.9  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 1,223.3      $ 1,185.7      $ 1,166.5      $ 1,160.3      $ 1,145.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended  
     March 31,      December 31,      September 30,      June 30,      March 31,  
     2023      2022      2022      2022      2022  

Managed Services Revenue

   $ 718.9      $ 699.8      $ 714.6      $ 717.9      $ 663.4  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     as of  
     March 31,      December 31,      September 30,      June 30,      March 31,  
     2023      2022      2022      2022      2022  

12-Month Backlog

   $ 4,110      $ 4,090      $ 3,970      $ 3,950      $ 3,890  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

 

#  #  #